Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $14,431 | 8 | 63.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $6,950 | 3 | 30.4% |
| Travel and Lodging | $809.22 | 2 | 3.5% |
| Food and Beverage | $650.50 | 9 | 2.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $10,690 | 9 | $0 (2023) |
| Eli Lilly and Company | $3,400 | 6 | $0 (2024) |
| Focal Therapeutics, Inc. | $3,375 | 1 | $0 (2021) |
| HOLOGIC INC | $2,250 | 1 | $0 (2021) |
| Bayer HealthCare Pharmaceuticals Inc. | $1,446 | 1 | $0 (2021) |
| Foundation Medicine, Inc. | $1,029 | 2 | $0 (2021) |
| Janssen Research & Development, LLC | $620.00 | 1 | $0 (2022) |
| Puma Biotechnology, Inc. | $30.46 | 1 | $0 (2018) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $41.55 | 1 | Eli Lilly and Company ($41.55) |
| 2023 | $3,675 | 3 | AstraZeneca Pharmaceuticals LP ($2,875) |
| 2022 | $620.00 | 1 | Janssen Research & Development, LLC ($620.00) |
| 2021 | $7,100 | 4 | Focal Therapeutics, Inc. ($3,375) |
| 2019 | $39.91 | 1 | Eli Lilly and Company ($39.91) |
| 2018 | $7,846 | 8 | AstraZeneca Pharmaceuticals LP ($7,815) |
| 2017 | $3,518 | 4 | Eli Lilly and Company ($2,518) |
All Payment Transactions
22 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/10/2024 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $41.55 | General |
| 12/13/2023 | AstraZeneca Pharmaceuticals LP | — | Consulting Fee | Cash or cash equivalent | $2,740.00 | General |
| 12/11/2023 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $800.00 | General |
| 12/05/2023 | AstraZeneca Pharmaceuticals LP | — | Food and Beverage | In-kind items and services | $135.00 | General |
| 06/21/2022 | Janssen Research & Development, LLC | — | Consulting Fee | Cash or cash equivalent | $620.00 | General |
| 12/16/2021 | Bayer HealthCare Pharmaceuticals Inc. | Vitrakvi (Drug) | Consulting Fee | Cash or cash equivalent | $1,446.00 | General |
| Category: Oncology | ||||||
| 08/09/2021 | HOLOGIC INC | — | Consulting Fee | Cash or cash equivalent | $2,250.00 | General |
| 06/16/2021 | Foundation Medicine, Inc. | FOUNDATIONONE (Device), FOUNDATIONONE HEME, FOUNDATIONONE CDX | Food and Beverage | In-kind items and services | $29.04 | General |
| Category: ONCOLOGY | ||||||
| 03/15/2021 | Focal Therapeutics, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,375.00 | General |
| 09/09/2019 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $39.91 | General |
| 12/04/2018 | Puma Biotechnology, Inc. | Nerlynx (Drug) | Food and Beverage | In-kind items and services | $30.46 | General |
| Category: Oncology | ||||||
| 09/06/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,600.00 | General |
| Category: Oncology | ||||||
| 08/30/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $27.69 | General |
| Category: Oncology | ||||||
| 05/22/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $3,200.00 | General |
| Category: Oncology | ||||||
| 05/14/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Travel and Lodging | In-kind items and services | $581.22 | General |
| Category: Oncology | ||||||
| 05/14/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $131.47 | General |
| Category: Oncology | ||||||
| 03/19/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,150.00 | General |
| Category: Oncology | ||||||
| 03/14/2018 | AstraZeneca Pharmaceuticals LP | LYNPARZA (Drug) | Food and Beverage | In-kind items and services | $125.00 | General |
| Category: Oncology | ||||||
| 12/07/2017 | Eli Lilly and Company | — | Consulting Fee | Cash or cash equivalent | $2,200.00 | General |
| 12/04/2017 | Eli Lilly and Company | — | Travel and Lodging | In-kind items and services | $228.00 | General |
| 12/04/2017 | Eli Lilly and Company | — | Food and Beverage | In-kind items and services | $90.38 | General |
| 07/10/2017 | Foundation Medicine, Inc. | FOUNDATIONACT (Device), FOUNDATIONONE HEME, FOUNDATIONONE | Consulting Fee | Cash or cash equivalent | $1,000.00 | General |
| Category: ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 35 | 73 | $25,692 | $5,109 |
| 2022 | 1 | 16 | 43 | $13,674 | $2,862 |
| 2021 | 1 | 11 | 28 | $8,904 | $1,846 |
All Medicare Procedures & Services
4 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 24 | 52 | $16,536 | $3,296 | 19.9% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 11 | 21 | $9,156 | $1,813 | 19.8% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 16 | 43 | $13,674 | $2,862 | 20.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 11 | 28 | $8,904 | $1,846 | 20.7% |
About Dr. Ben Park, M.D
Dr. Ben Park, M.D is a Hematology healthcare provider based in Nashville, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/07/2006. The National Provider Identifier (NPI) number assigned to this provider is 1407896509.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ben Park, M.D has received a total of $22,841 in payments from pharmaceutical and medical device companies, with $41.55 received in 2024. These payments were reported across 22 transactions from 8 companies. The most common payment nature is "Consulting Fee" ($14,431).
As a Medicare-enrolled provider, Park has provided services to 62 Medicare beneficiaries, totaling 144 services with total Medicare billing of $9,816. Data is available for 3 years (2021–2023), covering 4 distinct procedure/service records.
Practice Information
- Specialty Hematology
- Other Specialties Hematology & Oncology
- Location Nashville, TN
- Active Since 06/07/2006
- Last Updated 01/21/2024
- Taxonomy Code 207RH0000X
- Entity Type Individual
- NPI Number 1407896509
Products in Payments
- LYNPARZA (Drug) $7,815
- Vitrakvi (Drug) $1,446
- FOUNDATIONACT (Device) $1,000
- Nerlynx (Drug) $30.46
- FOUNDATIONONE (Device) $29.04
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology Doctors in Nashville
Dr. Navneet Majhail, Md, MD
Hematology — Payments: $62,360
Dr. Michael Debaun, Md, MD
Hematology — Payments: $39,880
Dr. Jill Gilbert, Md, MD
Hematology — Payments: $14,607
Wesam Ahmed, Md, MD
Hematology — Payments: $11,770
Dr. Katherine Walsh, M.d, M.D
Hematology — Payments: $7,046
Emily Chan, Md, Phd, MD, PHD
Hematology — Payments: $2,950